AI Buyer Insights:

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Addex Therapeutics Ltd Tech Stack and Enterprise Applications

Addex Therapeutics Ltd ERP Services and Operations
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
GraphPad Software Legacy Dotmatics Luma Laboratory Management ERP Services and Operations n/a 2023 2023
In 2023 Addex Therapeutics Ltd centralized and modernized its small-molecule drug discovery data on Dotmatics Luma as the company platform for Laboratory Management. The initiative targeted consolidation of experimental and assay datasets to improve data access and accelerate analysis for R&D teams based in Switzerland. The implementation emphasized a centralized data repository, standardized analytical workflows, and configurable visualization and reporting capabilities consistent with Laboratory Management systems. Dotmatics Luma was used to unify experiment records, enable interactive analytics across chemistry and assay results, and provide searchable, curated datasets for bench scientists and data analysts. Operational scope covered Addex R&D groups in Switzerland, prioritizing day to day lab operations, data analysis, and cross functional collaboration between chemists and biologists. The deployment approach included staged adoption and plans for future roll out of additional Dotmatics functionality to broaden coverage across R&D workflows. Governance focused on standardizing data models and establishing repeatable analysis workflows to reduce manual data handling and improve reproducibility within Laboratory Management processes. The case study reports an approximately 50% reduction in time spent analysing data for R&D teams following adoption of Dotmatics Luma.
Addex Therapeutics Ltd Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2019 2019
In 2019, Addex Therapeutics Ltd deployed Microsoft 365 to establish a Collaboration platform for its Switzerland based life sciences operations. The Microsoft 365 implementation is reported as being used on the company website and across the organization, aligning cloud productivity with corporate communications for a 26 person workforce. Configuration focused on core Microsoft 365 Collaboration capabilities, leveraging services commonly associated with the suite such as Exchange Online for email, SharePoint Online for document and content hosting, Microsoft Teams for real time collaboration, and OneDrive for Business for file synchronization. These services provide a consolidated collaboration layer to support corporate email, document management, intranet style content and team collaboration workflows consistent with the Collaboration category. Operational ownership appears scoped to the internal organization, with tenant administration, user provisioning and access controls adjusted for a small enterprise environment. Surface presence of Microsoft 365 on the corporate website indicates the platform is used for outward facing content and corporate communications, while internal governance likely focuses on simple role based access and content publishing workflows appropriate to a 26 employee life sciences company.
Addex Therapeutics Ltd Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Concrete CMS Legacy Concrete CMS Web Content Management Content Management n/a 2018 2018
In 2018, Addex Therapeutics Ltd implemented Concrete CMS for Web Content Management of its corporate website. Concrete CMS is used to centralize public site content, manage pages and publish company information for marketing and investor relations. The implementation is aligned with the operational scale of a 26 person life sciences company, emphasizing straightforward content authoring and public site maintenance. Typical configuration includes Concrete CMS page templates, a visual editor for in browser content editing, an asset library for images and documents, SEO metadata fields, and role based permissions to support editorial workflows. Operational ownership is concentrated in commercial functions, including marketing and communications, which use Concrete CMS to control site updates and corporate messaging. This establishes Addex Therapeutics Ltd Concrete CMS Web Content Management relationship for the company website.
Addex Therapeutics Ltd IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Hosting and Computing Services IaaS 2018 2018
Addex Therapeutics Ltd CyberSecurity
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Secure Email Gateways (SEGs) CyberSecurity 2019 2019

IT Decision Makers and Key Stakeholders at Addex Therapeutics Ltd

First Name Last Name Title Function Department Email Phone
No data found

Apps Being Evaluated by Addex Therapeutics Ltd Executives

APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Addex Therapeutics Ltd IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Addex Therapeutics Ltd digital transformation priorities and AI adoption trends.
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Addex Therapeutics Ltd Technographics
Addex Therapeutics Ltd is a Life Sciences organization based in Switzerland, with around 26 employees and annual revenues of $2.7 million.
Addex Therapeutics Ltd operates a diverse technology stack with applications such as Dotmatics Luma, Microsoft 365 and Concrete CMS, covering areas like Laboratory Management, Collaboration and Web Content Management.
Addex Therapeutics Ltd has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as GraphPad Software, Microsoft and Concrete CMS.
Addex Therapeutics Ltd recently adopted applications including Dotmatics Luma in 2023, Microsoft 365 in 2019 and Mimecast Email Security in 2019, highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Addex Therapeutics Ltd’s key decision makers and IT executives, available to Premium subscribers.
Our research team continuously updates Addex Therapeutics Ltd’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Addex Therapeutics Ltd technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.